Ebola virus disease (EVD), also known simply as Ebola is a viral hemorrhagic fever in humans and other primates, which manifests between two days and three weeks after contracting the virus.
The director of the national agency for health security in Guinea, Dr. Kelta Sakoba and his team stated how proud they are of being able to contribute a developing vaccine that will help other nations to lessen out the Ebola victims like what they endured.
Ebola vaccine proves to be fully effective in fighting the virus.
With the slowing down of recent Ebola infects in Guinea and Sierra Leone, the chances of testing experimental Ebola vaccines are slim to none.